Macro partitioning
Combining GLP-1 receptor agonists with structured exercise (specifically resistance training) mitigates the loss of lean body mass associated with pharmacological weight loss, whereas GLP-1 agonists alone result in significant lean mass loss.
If you are on a GLP-1 medication like semaglutide or tirzepatide, you must incorporate resistance training (2-3 times per week) into your routine. The medication will cause you to lose muscle along with fat (up to 40% of weight loss). Resistance training preserves this muscle, maintaining your metabolism and strength. Combine this with moderate aerobic activity (150 mins/week) and adequate protein intake for the best long-term results.
Combining GLP-1 receptor agonists with structured lifestyle changes, especially increased protein intake and strength training, can mitigate muscle loss and enhance overall outcomes.
Why this rating
Based on a narrative review of multiple RCTs and meta-analyses (e.g., STEP-1, SURMOUNT-1) showing consistent lean mass loss with drugs and preservation with exercise.
Source
GLP-1 agonists and exercise: the future of lifestyle prioritization
Roberto Codella et al. · Frontiers in Clinical Diabetes and Healthcare · 2025
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →